Mark Mellow

3.6k total citations · 2 hit papers
16 papers, 2.3k citations indexed

About

Mark Mellow is a scholar working on Infectious Diseases, Epidemiology and Gastroenterology. According to data from OpenAlex, Mark Mellow has authored 16 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Epidemiology and 6 papers in Gastroenterology. Recurrent topics in Mark Mellow's work include Clostridium difficile and Clostridium perfringens research (10 papers), Microscopic Colitis (6 papers) and Gut microbiota and health (4 papers). Mark Mellow is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (10 papers), Microscopic Colitis (6 papers) and Gut microbiota and health (4 papers). Mark Mellow collaborates with scholars based in United States, France and Canada. Mark Mellow's co-authors include Lawrence J. Brandt, Christina M. Surawicz, Ashwin N. Ananthakrishnan, Scott Curry, Peter H. Gilligan, David G. Binion, Brian S. Zuckerbraun, Lynne V. McFarland, Colleen Kelly and Amy Kanatzar and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and The American Journal of Gastroenterology.

In The Last Decade

Mark Mellow

16 papers receiving 2.2k citations

Hit Papers

Guidelines for Diagnosis, Treatment, and Prevention of Cl... 2012 2026 2016 2021 2013 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
    2013 1.2k citations Christina M. Surawicz, Lawrence J. Brandt et al. The American Journal of Gastroenterology profile →
  2. Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection
    2012 524 citations Lawrence J. Brandt, Olga C. Aroniadis et al. The American Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Mellow United States 11 1.8k 1.4k 711 608 603 16 2.3k
Scott Curry United States 13 2.0k 1.1× 1.4k 1.0× 308 0.4× 317 0.5× 445 0.7× 32 2.1k
Patricia P. Kammer United States 20 1.0k 0.6× 1.3k 1.0× 539 0.8× 197 0.3× 507 0.8× 47 1.9k
Bastiaan W. Haak Netherlands 18 523 0.3× 294 0.2× 67 0.1× 835 1.4× 152 0.3× 41 1.4k
Y Arabi United Kingdom 20 765 0.4× 517 0.4× 104 0.1× 172 0.3× 696 1.2× 32 1.7k
Yael R. Nobel United States 13 465 0.3× 186 0.1× 124 0.2× 363 0.6× 289 0.5× 30 1.1k
François Lamothe Canada 13 811 0.4× 590 0.4× 82 0.1× 85 0.1× 176 0.3× 16 1.0k
Annalisa Passariello Italy 22 251 0.1× 207 0.2× 353 0.5× 352 0.6× 548 0.9× 53 1.9k
Claire Nour Abou Chakra Canada 15 624 0.3× 641 0.5× 62 0.1× 54 0.1× 224 0.4× 28 998
Fred A. Zar United States 10 966 0.5× 847 0.6× 113 0.2× 61 0.1× 281 0.5× 19 1.2k
Germana V. Gregorio United Kingdom 21 401 0.2× 907 0.7× 172 0.2× 343 0.6× 359 0.6× 38 2.0k

Countries citing papers authored by Mark Mellow

Since Specialization
Citations

This map shows the geographic impact of Mark Mellow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mellow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mellow more than expected).

Fields of papers citing papers by Mark Mellow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Mellow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mellow. The network helps show where Mark Mellow may publish in the future.

Co-authorship network of co-authors of Mark Mellow

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Mellow. A scholar is included among the top collaborators of Mark Mellow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Mellow. Mark Mellow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fischer, Monika, Dina Kao, Colleen Kelly, et al.. (2016). Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 22(10). 2402–2409. 134 indexed citations
2.
Aroniadis, Olga C., Lawrence J. Brandt, Adam Eric Greenberg, et al.. (2015). Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection. Journal of Clinical Gastroenterology. 50(5). 398–402. 78 indexed citations
3.
Austin, Matthew, Mark Mellow, & William M. Tierney. (2014). Fecal Microbiota Transplantation in the Treatment of Clostridium difficile Infections. The American Journal of Medicine. 127(6). 479–483. 56 indexed citations
4.
Fischer, Monika, Colleen Kelly, Dina Kao, et al.. (2014). Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Patients With Inflammatory Bowel Disease: Presidential Poster. The American Journal of Gastroenterology. 109. S487–S487. 1 indexed citations
5.
Surawicz, Christina M., Lawrence J. Brandt, David G. Binion, et al.. (2013). Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. The American Journal of Gastroenterology. 108(4). 478–498. 1223 indexed citations breakdown →
6.
Aroniadis, Olga C., Lawrence J. Brandt, Adam Eric Greenberg, et al.. (2013). 998 Long-Term Follow-up Study of Fecal Microbiota Transplantation (FMT) for Severe or Complicated Clostridium difficile Infection (CDI). Gastroenterology. 144(5). S–185. 12 indexed citations
7.
Orr, William C., et al.. (2012). The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: a randomized, cross‐over trial. Neurogastroenterology & Motility. 24(6). 553–553. 44 indexed citations
8.
Brandt, Lawrence J., Olga C. Aroniadis, Mark Mellow, et al.. (2012). Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection. The American Journal of Gastroenterology. 107(7). 1079–1087. 524 indexed citations breakdown →
9.
Mellow, Mark, Vivek Kohli, Sajid Jalil, & Nicolas Jabbour. (2012). Persistent Clostridium difficile Infection in a Patient with Decompensated Liver Disease: “Double Transplant” Saves a Life!. The American Journal of Gastroenterology. 107. S461–S461. 2 indexed citations
10.
Mellow, Mark, Amy Kanatzar, Lawrence J. Brandt, et al.. (2011). Longterm Follow-up of Colonoscopic Fecal Microbiota Transplant (FMT) for Recurrent C. difficile Infection (RCDI): ACG Governors Award for Excellence in Clinical Research. The American Journal of Gastroenterology. 106. S149–S150. 5 indexed citations
11.
Mellow, Mark & Amy Kanatzar. (2010). Colonoscopic Fecal Bacteriotherapy in the Treatment of Recurrent Clostridium Difficile Infection - Results and Follow-up. The American Journal of Gastroenterology. 105. S135–S135. 18 indexed citations
12.
Jacobs, Walter H., Stanley B. Goldberg, John A. Balint, et al.. (1989). Statement on outpatient percutaneous liver biopsy. Digestive Diseases and Sciences. 34(3). 322–323. 78 indexed citations
13.
Allen, Melvin L., Mark Mellow, Merrel Robinson, & William C. Orr. (1987). Comparison of calcium channel blocking agents and an anticholinergic agent on oesophageal function. Alimentary Pharmacology & Therapeutics. 1(2). 153–159. 23 indexed citations
14.
Mellow, Mark. (1977). Symptomatic Diffuse Esophageal Spasm. Gastroenterology. 73(2). 237–240. 77 indexed citations
15.
Thiel, David H. Van, et al.. (1974). Tolazamide Hepatotoxicity. Gastroenterology. 67(3). 506–510. 5 indexed citations
16.
Dh, Van Thiel, et al.. (1974). Tolazamide hepatotoxicity. A case report.. PubMed. 67(3). 506–10. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott Curry Breakdown of academic impact, for papers by Patricia P. Kammer Breakdown of academic impact, for papers by Bastiaan W. Haak Breakdown of academic impact, for papers by Y Arabi Breakdown of academic impact, for papers by Yael R. Nobel Breakdown of academic impact, for papers by François Lamothe Breakdown of academic impact, for papers by Annalisa Passariello Breakdown of academic impact, for papers by Claire Nour Abou Chakra Breakdown of academic impact, for papers by Fred A. Zar Breakdown of academic impact, for papers by Germana V. Gregorio
Rankless by CCL
2026